Merck Nordic Meetings

IPhone / Mobile Compatible

Domain Not Resolving

SSL by Default

Apple Mobile Web Clips Icon

HSTS

Google Font API

DNSSEC

Content Delivery Network

Font Awesome

LetsEncrypt

Regional General Counsel LatAm

Alejandro Torrendell

CFO UK & Ireland

Alison Massey

General Manager

Christina Shasserre

Chief Financial Officer

Satya Balyan

CFO Nordic and Baltic States

Tiina Puhakka

Vice President, Corporate and Government Relations USA

Christine Bugos

Vice President Human Resources

Dan Drellich

Head of Operations

David Poggi

VP, Head of Global Portfolio Management, Valuation & Analytics

Ivan Kugener

Vice President of Western Europe & Middle East Operations

Martin McAuliffe

Elmar Schnee

Belén Garijo

Karl-Ludwig Kley

Marc Feiglin

Global Head Technology Scouting & Strategic Partnerships

Karim Bendhaou

Head of Africa Affairs

Uwe Gudat

Head of Safety Biosimilars

Raymond Behrendt

R&D Manager

Craig Roberts

AVP, Vaccines, Center for Observational and Real-World Evidence

Andrea Herrmann

Associate Director, Strategy Implementation Leader

Anna Lena Fritzsche

Manager People Analytics Consultancy & Organization Development

Moderna Therapeutics is a biotechnology company that specializes in vaccines and drug development.

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

Threshold Pharmaceuticals is focused on the development of drugs targeting Tumor Hypoxia, a low oxygen condition found in solid tumors.

Proteologix is a biotech company that develops drugs for treatment of autoimmune/inflammatory diseases and oncology.

European Union (EU) Companies With More Than 10 Employees (Top 10K)

European Union (EU) Companies With More Than $1M in Revenue (Top 10K)

Europe, Middle East, and Africa (EMEA) Companies With More Than $100M in Revenue (Top 10K)

Health Care Companies With More Than 10 Employees (Top 10K)

Merck (d.b.a. EMD Millipore in the U.S. and Canada) is a German chemical and pharmaceutical company. Merck, also known as “German Merck” and “Merck Darmstadt”, was founded in Darmstadt, Germany, in 1668, making it the world's oldest operating chemical and pharmaceutical company. The company was privately owned until going public in 1995. However, the Merck family still controls a majority (≈70%) of the company's shares.

Following World War I, Merck lost possession of its foreign sites, including the Merck & Co. subsidiary in the United States. Merck & Co., which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, is now an independent company.

Merck KGaA operates mainly in Europe, Africa, Asia, Oceania and Latin America. Since Merck & Co. holds the rights to the Merck name in the U.S. and Canada, the company operated under the umbrella brand EMD Chemicals in North America, and since 2010 as EMD Millipore (after the acquisition of Millipore Corporation), formed from the initials of Emanuel Merck, Darmstadt.

Founded in 1668 in Darmstadt, Merck KGaA of Darmstadt, Germany, is the world's oldest pharmaceutical and chemical company. The success of the export business to the United States led in 1887 to the establishment of an office in New York, which gave rise to their subsidiary [Merck & Co.](http://www.crunchbase.com/organization/merck-co-inc) four years later. Owing to World War I, Merck & Co. was expropriated in 1917. The two companies have been separate every since.


Merck KGaA Subsidiaries:

- [Merck Consumer Healthcare](http://www.crunchbase.com/organization/merck-consumer-healthcare)

- [Merck Performance Materials](http://www.crunchbase.com/organization/merck-performance-materials)

Scottish Enterprise

Grant - Merck

Darmstadt

Hessen

Germany

Europe

Merck

The 10 Biggest Rounds Of September: Safe Superintelligence’s $1B Raise Reigns Supreme

Merck and Michael J. Fox Foundation Collaborate to Advance Parkinson’s Research with Innovative Biomarker Technology

Schnelldorf Facility Upgrade: Merck Boosts Life Science Distribution Capacity

Merck: launches phase III trial in lung cancer

Merck Expands M LabTM Collaboration Center in Shanghai, Enhancing Biopharmaceutical Capabilities

Merck KGaA drops BTK inhibitor evobrutinib, marking end of road for blockbuster dreams

Merck Expands Biologics Testing Center in China to Support Local Biopharma Innovation

Merck's Healthcare division focuses on developing medicines and devices for conditions like cancer, multiple sclerosis, and fertility, aiming to improve patient care and treatment outcomes.

Merck provides a wide range of tools, services, and products for scientific research, including chemicals, biology tools, diagnostics, biomonitoring, and lab water systems.

Merck's Electronics sector develops materials and solutions for semiconductors, displays, and surface technologies, supporting advancements in digital living.

Merck offers solutions for every step of drug development, from upstream processing to downstream filtration, supporting biopharmaceutical manufacturing.

Merck leads in fertility treatments, offering recombinant hormones and technologies to support assisted reproductive treatments and improve outcomes.

Merck focuses on treatments for neurological and immune-mediated conditions, with a strong emphasis on multiple sclerosis care.

United States

North America

India

Asia

United Kingdom

France

Office 365

Akamai Intelligent Platform

Facebook

F5 NGINX

GlobalSign

Valimail

Amazon EC2

Symantec Email Security.Cloud

Merck owns M Ventures

Merck owns Millipore

Merck owns Merck - Surface Solutions Business

Merck owns Merck Accelerator

Merck owns ExploreBio

Merck owns EMD Performance Materials

MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.

news impact assignment basic	general	Mar 8, 2024 1:56 PM	f8be82b1
public peers	general
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Mar 8, 2024 1:56 PM	4ba0742f
company summary	general
signals	general
crunchbase trigger	general	Nov 22, 2024 7:44 AM	3afc8192
crunchbase profile	general	Nov 22, 2024 8:27 AM	7ddb9ac5
li profile	general
translate crunchbase fundingrounds	general	Nov 22, 2024 8:33 AM	c5bb5a91
peers	general
news basic	general	Mar 8, 2024 1:56 PM	7f809a84
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COM:MERCKGROUP

Merck

Last Close

141.75

25/11 09:24

Market Cap

65.02B

Beta: -

Volume Today

20.79K

Avg: -